Goldman Sachs’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6M | Sell |
2,271,486
-518,528
| -19% | -$2.42M | ﹤0.01% | 2231 |
|
|
2025
Q1 | $15.3M | Buy |
2,790,014
+1,199,435
| +75% | +$6.58M | ﹤0.01% | 1901 |
|
|
2024
Q4 | $5.39M | Buy |
1,590,579
+754,137
| +90% | +$2.56M | ﹤0.01% | 2802 |
|
|
2024
Q3 | $2.38M | Buy |
836,442
+520,778
| +165% | +$1.48M | ﹤0.01% | 3243 |
|
|
2024
Q2 | $710K | Buy |
315,664
+64,216
| +26% | +$144K | ﹤0.01% | 3769 |
|
|
2024
Q1 | $556K | Sell |
251,448
-7,241
| -3% | -$16K | ﹤0.01% | 3936 |
|
|
2023
Q4 | $608K | Buy |
258,689
+125,849
| +95% | +$296K | ﹤0.01% | 3853 |
|
|
2023
Q3 | $247K | Sell |
132,840
-91,302
| -41% | -$170K | ﹤0.01% | 4184 |
|
|
2023
Q2 | $587K | Buy |
224,142
+99,587
| +80% | +$261K | ﹤0.01% | 3893 |
|
|
2023
Q1 | $203K | Sell |
124,555
-39,285
| -24% | -$64K | ﹤0.01% | 4514 |
|
|
2022
Q4 | $218K | Buy |
163,840
+41,194
| +34% | +$54.8K | ﹤0.01% | 4471 |
|
|
2022
Q3 | $191K | Buy |
122,646
+10,106
| +9% | +$15.7K | ﹤0.01% | 4743 |
|
|
2022
Q2 | $173K | Sell |
112,540
-612,715
| -84% | -$942K | ﹤0.01% | 4950 |
|
|
2022
Q1 | $1.86M | Buy |
725,255
+497,564
| +219% | +$1.27M | ﹤0.01% | 3648 |
|
|
2021
Q4 | $667K | Buy |
227,691
+103,507
| +83% | +$303K | ﹤0.01% | 4325 |
|
|
2021
Q3 | $305K | Buy |
124,184
+26,190
| +27% | +$64.3K | ﹤0.01% | 4652 |
|
|
2021
Q2 | $399K | Buy |
97,994
+11,902
| +14% | +$48.5K | ﹤0.01% | 4548 |
|
|
2021
Q1 | $388K | Sell |
86,092
-132,152
| -61% | -$596K | ﹤0.01% | 4505 |
|
|
2020
Q4 | $1.07M | Buy |
218,244
+139,998
| +179% | +$689K | ﹤0.01% | 3416 |
|
|
2020
Q3 | $464K | Sell |
78,246
-82,286
| -51% | -$488K | ﹤0.01% | 3697 |
|
|
2020
Q2 | $427K | Buy |
160,532
+39,073
| +32% | +$104K | ﹤0.01% | 3667 |
|
|
2020
Q1 | $237K | Buy |
121,459
+102,759
| +550% | +$201K | ﹤0.01% | 3867 |
|
|
2019
Q4 | $132K | Sell |
18,700
-11,287
| -38% | -$79.7K | ﹤0.01% | 4092 |
|
|
2019
Q3 | $295K | Buy |
29,987
+12,774
| +74% | +$126K | ﹤0.01% | 3798 |
|
|
2019
Q2 | $197K | Sell |
17,213
-25,361
| -60% | -$290K | ﹤0.01% | 3883 |
|
|
2019
Q1 | $427K | Buy |
+42,574
| New | +$427K | ﹤0.01% | 3622 |
|
|
2018
Q3 | – | Sell |
-28,500
| Closed | -$541K | – | 4253 |
|
|
2018
Q2 | $541K | Buy |
+28,500
| New | +$541K | ﹤0.01% | 3486 |
|